(Q38676978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Hilary Humphreys

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

I Vickers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

J Mereckiene

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

S Murchan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

S Cotter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M Fitzgerald

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M McElligott

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M Cafferkey

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

D O'Flanagan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

R Cunney

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

1 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology and Infection

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

2390-2399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes.

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region - an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Rationale and prospects for novel pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Pneumococcal vaccination in older adults in the era of childhood vaccination: Public health insights from a Norwegian statistical prediction study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Pneumococcal Capsules and Their Types: Past, Present, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in Sicily

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Serotype replacement in disease after pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Adults with invasive pneumococcal disease: missed opportunities for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

inferred from DOI database lookup

7 January 2021

based on heuristic

Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

inferred from DOI database lookup

7 January 2021

based on heuristic

Pneumococcal serotype evolution in Western Europe

1 reference

https://api.crossref.org/works/10.1017%2FS0950268817001194

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S0950268817001194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28712384%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference